TABLE 3.
Quality indicators
| Organism reported | Drug tested (% susceptibility) | No. of ABGMs from hospitals with bed size of:
|
|||
|---|---|---|---|---|---|
| 0-50 | 51-250 | >250 | No. reported/ total | ||
| S. aureus | Beta-lactam (inconsistent) | 3 | 19 | 27 | 49/201 |
| Vancomycin (<100) | 0 | 10 | 3 | 13/198 | |
| Enterococcus spp. | Cephalosporins | 1 | 2 | 0 | 3/198 |
| Trimethoprim-sulfa- methoxazole | 2 | 1 | 0 | 3/198 | |
| E. coli | Imipenem (<100) | 3 | 13 | 18 | 34/170 |
| S. maltophilia | Imipenem (>0) | 1 | 2 | 14 | 17/39 |
| H. influenzae | Broad-spectrum ceph- alosporins (<100) | 0 | 4 | 6 | 10/33 |
| K. pneumoniae | Ampicillin (>0) | 3 | 27 | 48 | 78/160 |
| Total number of ABGMs | 11 | 74 | 124 | 209 | |